ctrl K

Watchlist Price Alert

Fusion Pharmaceuticals In... (FUSN)

NASDAQ: FUSN · Real-Time Price · USD

21.55

0.03 (0.14%)

At close: Jun 03, 2024, 8:00 PM

Fusion Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	2.07M	1.46M	1.44M	n/a	n/a	n/a	n/a
Cost of Revenue	1.34M	58.9M	56.36M	482K	290K	n/a	n/a
Gross Profit	723K	-57.43M	-54.92M	-482K	-290K	n/a	n/a
Operating Income	-99.23M	-88.03M	-82.02M	-37.94M	-18.22M	-10.1M	-6.99M
Interest Income	9.53M	2.16M	381K	327K	576K	n/a	n/a
Pretax Income	-94.11M	-89.45M	-81.17M	-75.72M	-15.94M	-11.47M	-6.26M
Net Income	-94.9M	-87.61M	-81.05M	-78.33M	-16.19M	-11.65M	-6.26M
Selling & General & Admin	31.2M	30.6M	27.1M	20.74M	7.59M	3.22M	1.62M
Research & Development	68.76M	58.9M	56.36M	17.19M	10.63M	6.88M	5.37M
Other Expenses	762K	-1.77M	469K	-31.71M	-176K	-1.71M	722K
Operating Expenses	99.95M	89.5M	83.45M	37.94M	18.04M	9.76M	6.99M
Interest Expense	5.17M	1.8M	n/a	327K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	101.3M	89.5M	83.45M	37.94M	18.04M	9.76M	6.99M
Income Tax Expense	787K	-1.84M	-118K	2.61M	251K	181K	n/a
Shares Outstanding (Basic)	65.61M	43.75M	42.6M	22.03M	155.71M	18.7M	18.7M
Shares Outstanding (Diluted)	65.61M	43.75M	42.6M	22.03M	155.71M	18.7M	18.7M
EPS (Basic)	-1.45	-2	-1.9	-3.56	-0.1	-0.62	-0.34
EPS (Diluted)	-1.45	-2	-1.9	-3.56	-0.1	-0.62	-0.34
EBITDA	-97.89M	-87.65M	-81.38M	-31.05M	-17.75M	-9.65M	-6.96M
EBIT	-88.94M	-87.65M	n/a	-75.39M	n/a	n/a	n/a
Depreciation & Amortization	1.34M	386K	634K	6.88M	466K	114K	23K